title: [Adapting the dose to the residual concentration of infliximab in cryptogenic inflammatory diseases of the intestines].
authors.forename: Philippe
authors.initials: P
authors.lastname: Chanson
authors.forename: Alexandre
authors.initials: A
authors.lastname: Pariente
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000097:blood*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000097:blood*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D016903:Drug Monitoring; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage* / Q000097:blood*; D006801:Humans; D008297:Male
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents